Noncontact Warming Therapy, Low Frequency Ultrasound Therapy, and Real-Time Fluorescence Wound Imaging for Wounds (Kansas)

Coverage Summary

Policy Number CS132KS.03; Geographic scope: Kansas (UnitedHealthcare Community Plan). Effective date: February 1, 2026. Headline: This policy addresses coverage and evidence for noncontact normothermic wound therapy (NNWT), low-frequency ultrasound therapies (including MIST Therapy® / NLFU), and noncontact real-time fluorescence wound imaging (e.g., MolecuLight i:X). Coverage stance: overall mixed — therapies are considered unproven and not medically necessary per the criteria summarized in the policy due to insufficient evidence of safety and/or efficacy.

Key policy facts

Therapies consideredNoncontact normothermic wound warming (NNWT), low-frequency ultrasound (including MIST Therapy®/NLFU), and noncontact real-time fluorescence wound imaging (e.g., MolecuLight i:X)

Geographic scopeKansas (UnitedHealthcare Community Plan medical policy applies to Kansas only)

Key referenced devices/studiesMIST Therapy®/UltraMIST, Warm-Up® Active Wound Therapy, MolecuLight i:X; cited RCTs, systematic reviews, meta-analyses, observational and pilot studies (e.g., Rahma 2022, Le et al. 2020/2021, Chen et al. 2023, Derwin 2023)

MolecuLight i:X evidence statusInconclusive — diagnostic accuracy and increased detection of bacterial load shown, but insufficient evidence that use improves patient-centered outcomes; additional RCTs needed

Quality/size of studies citedLimited — many small, single-center, pilot, observational studies; meta-analyses note small number and heterogeneity of trials; several RCTs small or underpowered

Regulatory status of MolecuLight i:XFDA 510(k) cleared (substantially equivalent via premarket notification)

Coverage Rationale and Evidence-based Conclusions

Procedure, CPT and HCPCS Codes

Procedure / CPT codes referenced (informational only)CPT

0598T	Real-time fluorescence wound imaging with clinical darkness, to identify location of bacterial wound pathogens and measure wound size, per session; first anatomic site (e.g., lower extremity, right leg).
0599T	Real-time fluorescence wound imaging with clinical darkness, to identify location of bacterial wound pathogens and measure wound size, per session; each additional anatomic site (e.g., upper extremity, left leg) (List separately in addition to code for primary procedure).
97610	Low frequency, non-contact, non-thermal ultrasound, including topical application(s), when performed, wound assessment, and instruction(s) for ongoing care, per day.

Durable Medical Equipment / HCPCS codes referenced (informational only)HCPCS

A6000	Noncontact wound-warming wound cover for use with the noncontact wound-warming device and warming card.
E0231	Noncontact wound-warming device (temperature control unit, AC adapter and power cord) for use with warming card and wound cover.
E0232	Warming card for use with the noncontact wound-warming device and noncontact wound warming-wound cover.

Applicable CPT / HCPCS codes (updated)CPT|HCPCS

0598T	Procedure code referenced; description was revised per policy history (see Applicable Codes and Policy History).
0599T	Procedure code referenced; description was revised per policy history (see Applicable Codes and Policy History).

Provider Impact and Billing Guidance

Prior Authorization

Prior authorization implication

Policy states NNWT, low-frequency ultrasound therapy, and noncontact fluorescence imaging are considered unproven and not medically necessary; providers should expect denials for these services unless applicable coverage exceptions or other benefit requirements apply. Affected codes: 0598T, 0599T, 97610, A6000, E0231, E0232.

Documentation Required

Evidence and documentation limitations

When submitting claims, appeals, or prior authorization requests, provide high-quality clinical evidence demonstrating patient benefit — ideally randomized controlled trials with adequate sample size, appropriate control groups, and sufficient follow-up. The policy cites limitations of existing studies (small samples, lack of controls, heterogeneity) as the basis for noncoverage decisions.

Include RCT data with adequate power and control arms.

Background and Evidence Summary

NNWT: Noncontact normothermic wound therapy uses a noncontact wound cover and a warming unit to apply radiant heat and maintain high humidity over a wound with the intent to raise wound temperature to increase blood flow and oxygenation.

Low-frequency ultrasound (e.g., MIST Therapy® / MIST Therapy System): a noncontact, low-frequency ultrasonic system that delivers ultrasonic energy via a saline mist from a handheld transducer (≈40 kHz) held near the wound; intended to cleanse, debride, reduce slough and bacteria, and stimulate cellular activities that may support healing.

MolecuLight i:X fluorescence imaging: a handheld, violet-light fluorescence imaging device that captures real-time fluorescent signals from bacteria in/wr around wounds to assist clinicians in locating bacterial load and documenting wound area for diagnostic and treatment decisions.

Study / Source	Key finding
Yue et al. (2018) systematic review
No RCTs comparing local warming therapy to standard care were found; insufficient evidence to draw conclusions about efficacy.
Chen et al. (2023) meta-analysis (ultrasound)
Some pooled analyses report lower non-healed wounds and greater area reduction with low‑frequency ultrasound, but small number of studies, heterogeneity, and need for validation by well‑designed studies.
Multiple RCTs and systematic reviews (various years)
Mixed results overall; many studies are small, have high risk of bias or lack controls; evidence insufficient to establish efficacy.
Prospective/observational MolecuLight studies (2019–2025)
Diagnostic accuracy and predictive associations reported (high sensitivity/specificity in some small studies), but clinical utility to improve patient‑centered outcomes remains unclear.
Rahma et al. (2022) RCT (pilot)
At 12 weeks, DFU healing: 45% with autofluorescence‑guided care vs 22% control; pilot RCT underpowered and results require confirmation in a fully powered trial.
Derwin et al. (2023)
Prospective observational study found ~46% wound area reduction and a stepwise correlation between fluorescence‑detected bacterial status and wound area reduction; single‑site small sample.
ECRI assessment (2021; updated 2024)
ECRI concluded evidence is inconclusive that MolecuLight i:X improves patient outcomes; additional RCTs needed.
Le et al. (2020/2021) observational study
350‑patient prospective observational study: clinical signs and symptoms missed ~85% of bacterial loads >10^4 CFU/g; MolecuLight increased sensitivity and accuracy for detection.

The evidence base for these technologies is limited by small sample sizes, single-site or pilot designs, heterogeneous study populations and interventions, lack of adequate control groups or randomization in many studies, short follow-up periods, and inconsistent outcome reporting. Meta-analyses and systematic reviews note heterogeneity and potential bias and call for additional well-designed randomized controlled trials to validate findings and determine clinical utility for patient-centered outcomes.

Definitions

NNWT: Noncontact normothermic wound therapy — uses a noncontact wound cover and warming unit to apply radiant heat and humidity to wounds.

NLFU / NCLF-US: Noncontact low-frequency ultrasound therapy — devices that deliver ultrasonic energy (often via saline mist or a handheld applicator) to wounds (e.g., MIST Therapy®) intended for cleansing, debridement, and stimulation of healing.

Fluorescence imaging (MolecuLight i:X): Handheld fluorescence imaging using violet light to visualize and document bacterial fluorescence in wounds in real time to assist targeting of debridement and sampling.

CSS: Clinical signs and symptoms of infection as assessed by standard checklists (for example, the International Wound Infection Institute checklist).

WAR: Wound area reduction — measurement of reduction in wound surface area over time used as a healing outcome metric.

Revision History

2026-02-01material changeLatest

Archived previous policy version CS132KS.02; Updated list of applicable CPT codes to reflect annual edits; revised description for 0598T and 0599T.